A Study Investigating the Safety, Absorption, and Elimination of Radioactively Labeled Etrumadenant, a New Compound in the Treatment of Cancer
Clinical trial NCT05411146 · COMPLETED
Trial details
- NCT number
- NCT05411146
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2022-07-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.